Abiopharma

Clinical trial NCT06744335 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 1282 → 1283 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT00911560 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01

Clinical trial NCT03881098: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04753879 updates: 1. completion date: 2029-12-01 → 2026-07-01 2. primary completion date: 2026-12-01 → 2026-07-01

Clinical trial NCT05523440: enrollment: 7 → 9 participants.

Clinical trial NCT07332442: start date: 2026-05-01 → 2026-05-18.

Clinical trial NCT06750107 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2028-12-30 → 2026-04-30 3. primary completion date: 2028-04-30 → 2026-04-30

Clinical trial NCT02454907 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-25 3. primary completion date: 2026-05-31 → 2026-04-09

Clinical trial NCT05485831 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 100 → 111 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03548506 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2022-04-01 → 2023-12-31 3. primary completion date: 2021-12-01 → 2023-12-31 4. enrollment type: ESTIMATED → ACTUAL